Investigación
Educación
Soluciones
Iniciar sesión
ES
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Medical Chemistry,
Faculty of Medicine,
Doctoral School of Molecular Medicine,
Department of Medical Chemistry, Faculty of Medicine
Eliza Guti has not added Biography.
If you are Eliza Guti and would like to personalize this page please email our Author Liaison for assistance.
The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC.
Cancer immunology, immunotherapy : CII Sep, 2022 | Pubmed ID: 35066605
University of Debrecen
Eliza Guti*,1,2,
Ákos Máté Bede*,1,3,
Csongor Váróczy*,1,3,
Csaba Hegedűs1,
Máté Á. Demény1,4,
László Virág1,4
1Department of Medical Chemistry, Faculty of Medicine, University of Debrecen,
2Doctoral School of Molecular Medicine, University of Debrecen,
3National Academy of Scientist Education, University of Debrecen,
4, ELKH-DE Cell Biology and Signaling Research Group
Privacidad
Condiciones de uso
Políticas
Contáctenos
RECOMIENDE A LA BIBLIOTECA
BOLETINES de JoVE
JoVE Journal
Colecciones de métodos
JoVE Encyclopedia of Experiments
Archivo
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centro de recursos académicos
Autores
Bibliotecarios
Acceso
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados